Years
1
Total Value
$3.0M
AAV
$3.0M
Guaranteed
$1.8M
Sentiment Analysis
The Blue Jays' signing of Max Scherzer for $3M has generated largely positive reactions, with most analysts viewing it as a shrewd low-risk, high-reward gamble on a future Hall of Famer. Media coverage has focused heavily on Scherzer's successful rehabilitation from his thumb injury, with multiple outlets praising his unconventional physical therapy approach and highlighting his determination to compete at age 39 as evidence he's not ready to fade away. Fans are split between excitement over landing a three-time Cy Young winner at bargain-basement pricing and skepticism about whether Mad Max can deliver meaningful innings after recent injury concerns, though most acknowledge the minimal financial commitment makes this an easy pill to swallow. This move aligns perfectly with Toronto's strategy of adding veteran depth while staying flexible financially, giving them a proven ace who could anchor their rotation if healthy or serve as valuable mentorship for their younger pitchers. Looking ahead, this signing has all the makings of either a brilliant steal if Scherzer's competitive fire translates to 150+ solid innings, or a harmless flyer that costs virtually nothing if his body finally betrays him—the kind of calculated risk that smart front offices should take every time.
Contract Value Index (CVI)
Blue Jays' signing of the player grades out as about market rate (C+), adding depth at player. The Blue Jays will need strong production to justify this investment at this price point.
Cast Your Verdict
Cast your verdict:
Quick Reaction
News & Buzz
Live Discussion
Auto-moderated fan forum with 5-minute speaker turns
Discussion
Loading discussion...